Associated Papers
Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus.
Ortega-Ayala A et al.
Pharmaceuticals (basel, Switzerland), 2025
41011206 (PubMed )
Supplement: pharmaceuticals-18-01335-s001.zip › pharmaceuticals-3834233-supplementary › Table_S7.pdf
Molecular Ancestry Across Allelic Variants of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Mexican-Mestizo DMT2 Patients.
Ortega-Ayala A et al.
Biomedicines, 2025
40426982 (PubMed )
Supplement: biomedicines-13-01156-s001.zip › Table_S1.pdf
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives.
Pinto-Merino Á et al.
Pharmaceutics, 2022
Male Infertility Knowledgebase: decoding the genetic and disease landscape.
Joseph S et al.
Database : the Journal of Biological Databases and Curation, 2021
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
Wolking S et al.
Clinical Pharmacokinetics, 2015
PharmGKB summary: Efavirenz pathway, pharmacokinetics.
McDonagh EM et al.
Pharmacogenetics and Genomics, 2015
ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort.
Zhu P et al.
Plos One, 2013
[Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
Dribnokhodova OP et al.
Eksperimental'naia I Klinicheskaia Farmakologiia, 2012
Select a paper to view details